Characteristics, Treatment Patterns, and Clinical Outcomes in Acute Myeloid Leukemia (AML) Patients Using Mylotarg - a US Real-World Study Using Electronic Medical Record Data
Latest Information Update: 10 Aug 2021
At a glance
- Drugs Gemtuzumab ozogamicin (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Pfizer
Most Recent Events
- 27 Oct 2020 Status changed from active, no longer recruiting to completed.
- 02 Jun 2020 Planned End Date changed from 4 Jun 2020 to 31 Jul 2020.
- 02 Jun 2020 Planned primary completion date changed from 4 Jun 2020 to 31 Jul 2020.